Drug Database
Back to search

Netherlands· NL-66860b681950

Deqsiga 100 mg/ml oplossing voor infusie

A humane immunglobuline, unspezifisch, intravaskulär product containing humaan, normaal immunoglobuline, registered in Netherlands by Takeda Manufacturing Austria AG. The same ATC class is registered in 11 of our 19 countries.

ATC J06BA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDeqsiga 100 mg/ml oplossing voor infu…ATCJ06BA02REGISTER NO.NL-66860b681950PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about humaan, normaal immunoglobulineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Humane immunglobuline, unspezifisch, intravaskulär is registered in 11 of 19 countries.

Countries holding a registration under ATC J06BA02 (humane immunglobuline, unspezifisch, intravaskulär), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search humane immunglobuline, unspezifisch, intravaskulär products by name

Humane immunglobuline, unspezifisch, intravaskulär · ATC J06BA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HUMAAN, NORMAAL IMMUNOGLOBULINE
Manufacturer
Takeda Manufacturing Austria AG
Country
Netherlands (NL)
ATC code
J06BA02
ATC class
Humane Immunglobuline, unspezifisch, intravaskulär
Defined daily dose
1.6 g, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/25/1919

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

48 interactions on record for humane immunglobuline, unspezifisch, intravaskulär.

Graded by severity as the source publishes them — 44 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check humane immunglobuline, unspezifisch, intravaskulär against other medicinesHow interaction checks work

Humane immunglobuline, unspezifisch, intravaskulär · interactions on record

48 records

  • 44 severe
  • 4 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J06BA02

Humane immunglobuline, unspezifisch, intravaskulär, as other registers publish it.

All humane immunglobuline, unspezifisch, intravaskulär products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c25351f7-1390-4138-bdac-9c0bd5c9959d
GET /v1/drugs/c25351f7-1390-4138-bdac-9c0bd5c9959d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/deqsiga-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Immunoglobulins, Normal Human, For Intravascular Adm.",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp133177",
  "excipients": [
    "GLYCINE (E 640)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "HUMAAN, NORMAAL IMMUNOGLOBULINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2025/05/02",
  "procedure_number": "EMEA/H/C/006423",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/25/1919",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about humane immunglobuline, unspezifisch, intravaskulär.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console